Literature DB >> 12115847

Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations.

Serena D Webb1, Stephen L Golledge, Jeffrey L Cleland, John F Carpenter, Theodore W Randolph.   

Abstract

Recombinant human interferon-gamma (rhIFN-gamma) was lyophilized or spray-lyophilized in 9.5% trehalose, +/- 0.12% polysorbate 20 in 10 mM potassium phosphate, pH 7.5. We measured recovery of soluble protein after spraying, freeze-thawing, and drying and reconstitution. Infrared spectroscopy showed rhIFN-gamma secondary structure to be native-like in all dried powders. Powders were characterized using electron spectroscopy for chemical analysis, time-of-flight secondary ion mass spectroscopy, X-ray diffraction, and gas adsorption isotherms. rhIFN-gamma adsorbed at air/liquid interfaces during spraying, and to ice/liquid interfaces during lyophilization. The concentration of rhIFN-gamma at ice/liquid interfaces was approximately one-fourth that adsorbed at air/liquid interfaces. Addition of 0.12% polysorbate 20 reduced the concentration of rhIFN-gamma at both interfaces. Time-of-flight secondary ion mass spectroscopy detected polysorbate 20 on surfaces of lyophilized powders. Lyophilized samples dried more slowly but reconstituted more quickly than spray-lyophilized samples. rhIFN-gamma aggregated after nebulization, but aggregation decreased in 0.12% polysorbate 20. Addition of 0.12% polysorbate 20 reduced protein surface adsorption and decreased but did not completely prevent aggregation. Insignificant aggregation occurred after exposure to ice/liquid interfaces, but subsequent drying and reconstitution caused aggregation. The majority of the aggregation is due to adsorption at air-liquid and solid-air interfaces formed during spray-lyophilization or lyophilization. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115847     DOI: 10.1002/jps.10135

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa.

Authors:  Xichdao C Nguyen; John D Herberger; Paul A Burke
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

2.  Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.

Authors:  Ahmad M Abdul-Fattah; Vu Truong-Le; Luisa Yee; Emilie Pan; Yi Ao; Devendra S Kalonia; Michael J Pikal
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Formation of stable submicron protein particles by thin film freezing.

Authors:  Joshua D Engstrom; Edwina S Lai; Baltej S Ludher; Bo Chen; Thomas E Milner; Robert O Williams; G Barrie Kitto; Keith P Johnston
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

4.  Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface.

Authors:  Dilip Devineni; Christoph Gonschorek; Marcus T Cicerone; Yemin Xu; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2014-05-21       Impact factor: 5.571

5.  Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying.

Authors:  Nathan E Wilson; Tarun Tejasvi Mutukuri; Dmitry Y Zemlyanov; Lynne S Taylor; Elizabeth M Topp; Qi Tony Zhou
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.200

Review 6.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

7.  Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.

Authors:  Ashlee D Brunaugh; Tian Wu; Sekhar R Kanapuram; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2019-08-26       Impact factor: 4.939

8.  A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.

Authors:  Xinran Li; Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2015-02-28       Impact factor: 9.776

9.  Investigation of processing parameters of spray freezing into liquid to prepare polyethylene glycol polymeric particles for drug delivery.

Authors:  Melisa K Barron; Timothy J Young; Keith P Johnston; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

10.  Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.

Authors:  Amber L Clausi; Andrea Morin; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.